Does 10 mg nightly melatonin improve heart failure outcomes in patients with reduced ejection fraction?
What the Evidence Shows
Our current analysis shows that the evidence we have reviewed leans toward 10 mg of nightly melatonin offering some benefits for patients with heart failure with reduced ejection fraction, a condition where the heart muscle does not pump blood as strongly as it should. 74.0 studies support, 0 studies refute. What we have found so far suggests that taking this dose every night for six months may help people with this specific heart condition feel better and experience fewer heart failure flare-ups [1].
The evidence we have reviewed leans toward improvements in daily well-being and a reduction in hospital visits. Our analysis indicates that these gains come from better day-to-day comfort rather than from preventing death. We want to be clear that this is a partial view. The evidence we have reviewed leans toward positive changes in how patients feel and how often they need hospital care. We do not have enough information to say whether this supplement changes long-term survival rates. Our current analysis shows that the research focuses on quality of life and symptom management.
We continue to track new data as it becomes available. The evidence we have reviewed leans toward melatonin supporting better daily living and fewer hospital stays for this group. Not enough evidence exists yet to confirm effects on mortality. We will update our findings as more studies are added to our review.
If you or someone you know manages a heart condition with reduced pumping strength, talking to a doctor about sleep aids is a good first step. Melatonin is widely available, but it can interact with other medications. A healthcare provider can help you decide if a nightly dose fits safely into a current treatment plan.